Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance

BACKGROUND: The effects of neoadjuvant chemotherapy on immune markers remain largely unknown. The specific aim of this study was to assess stromal tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) protein expression in a cohort of breast cancer patients treated with neoadju...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelekanou, Vasiliki, Carvajal-Hausdorf, Daniel E., Altan, Mehmet, Wasserman, Brad, Carvajal-Hausdorf, Cristobal, Wimberly, Hallie, Brown, Jason, Lannin, Donald, Pusztai, Lajos, Rimm, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547502/
https://www.ncbi.nlm.nih.gov/pubmed/28784153
http://dx.doi.org/10.1186/s13058-017-0884-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547502/
https://www.ncbi.nlm.nih.gov/pubmed/28784153
http://dx.doi.org/10.1186/s13058-017-0884-8

Ejemplares similares